Last reviewed · How we verify
NCT04991272
10 Minutes Prewarming and Warmed Intravenous Fluid on Core Temperature
NA trial testing prewarming and warmed fluid infusion in Urologic Diseases in 57 participants. Completed in 25 August 2022.
25 August 2022
Quick facts
| Lead sponsor | Inje University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 57 |
| Start date | 1 July 2021 |
| Primary completion | 25 August 2022 |
| Estimated completion | 25 August 2022 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- prewarming and warmed fluid infusion
Conditions studied
- Urologic Diseases — all drugs for Urologic Diseases →
Sponsor
Inje University
Who can join
Adults 20 to 90, any sex, with Urologic Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hypothermia occurs frequently during general anesthesia. This study is to evaluate the efficacy of 10 minutes of prewarming and warmed fluid during urologic surgery.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effect of 10 Minutes of Prewarming and Prewarmed Intravenous Fluid Administration on the Core Temperature of Patients Undergoing Transurethral Surgery under General Anesthesia.
Cho J, Lee JM, Kim KM, Yon JH, et al · · 2024 · cited 9× · PMID 38164352 · DOI 10.7150/ijms.88943
Verify or expand the search:
- PubMed search for NCT04991272
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Urologic Diseases
Currently open trials in the same condition.
- NCT07378358 — Evaluation of AI Large Models for Diagnosis and Treatment in Real-World Cases: Multicenter Retrospective Study · recruiting
- NCT07338292 — VIrtual Reality Induced Pain and anxiEty Relief in Outpatient UROlogical Procedures · NA · recruiting
- NCT06676527 — Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma · recruiting
- NCT06531473 — Laser Outcomes Associated With (Holmium Laser Enucleation of the Prostate) HoLEP Procedures · NA · recruiting
- NCT07395037 — A Study of Ward Admissions for Haematuria · recruiting
Other Inje University trials
Trials by the same sponsor.
- NCT07318428 — AI-Assisted Detection of Posterior Segment Diseases: DR, AMD, RVO, and Glaucoma · NA · enrolling by invitation
- NCT05636189 — Effect of Prewarming During Induction of General Anesthesia Combined With Warmed Intravenous Fluid on Core Temperature. · NA · completed
- NCT05766644 — App-based Education Program for CKD · NA · unknown
- NCT05514405 — Effect of Remimazolam and Propofol on Postoperative Delirium · NA · recruiting
- NCT05439057 — Effect of Remimazolam on Postoperative Nausea and Vomiting · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04991272 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Inje University
- Last refreshed: 25 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04991272.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing